(S,S)-(+)-N,N’-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II)

We are (S,S)-(+)-N,N’-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) CAS:188264-84-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Synonyms:
(-)-1,2-bis((2S,5S)-2,5-diisiopropyl phosphorano) benzene
(S,S)-Fmoc-trans-2-aminocyclopentanecarboxylic acid-OH
(S,S)-Jocobsen's catalyst
(1S,2S)-2-(9H-fluoren-9-ylmethoxycarbonyl)amino-cyclopentanecarboxylic acid
Fmoc-(S,S)-2-aminocyclopentanecarboxylic acid
(1S,2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}cyclopentane-1-carboxylic acid
1,2-bis(2,5-diisopropylphospholano)benzene
(S,S)-Co-salen complex
Fmoc-(S,S)-ACPC
(S,S)-iPrDuPhos
Cyclopentanecarboxylicacid,2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-,(1S,2S)
(S,S)-(-)-N-N'-bis(3,5-di-tert-butylsalicylidine)-1,2-cyclohexanediaminocobalt-II
(R,R)-i-Pr-DuPhos
(S,S)-(+)-N,N'-BIS(3,5-DI-TERT-BUTYLSALICYLIDENE)-1,2-CYCLOHEXANEDIAMINO-COBALT(II)
Jacobsen's (S,S)-(salen)Co(III) catalyst
(S,S)-(salen)Co(II)
(S,S)-Co-Salen
(S,S)-Fmoc-trans-2-aminocyclopentanecarboxylic acid
(S,S)-Fmoc-ACPC-OH
 
Molecular Formula:  C36H54CoN2O2
Molecular Weight: 605.75900

Items of Analysis Standard of Analysis Test Results
Appearance Red to red brown solid Red solid
Assay (Element analysis) ≥98.0% 98.2%
Solvent ≤0.50% Conform
Conclusion Conforms to Factory Standard
 

 

(S,S)-(+)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II)


Related News: The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application.1,2-Dihydroxy-1,2-bis-(5-benzyloxy-4-oxo-pyranyl-(2))-aethen As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.4-((5-(3-(2-oxo-1-phenylpyrrolidin-3-yl)propyl)-1H-imidazol-1-yl)methyl)benzonitrile hydrochloride As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.2-Pyridinol-1-oxide Taiwan complained on Sunday that it was being punished because the World Health Organization considers it part of China, which has been subject to travel bans as the coronavirus spreads.In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.

Related Products
Product Name
dodecanoic acid Cas:143-07-7 View Details
2-Amino-3-bromo-5-methylpyridine View Details
CAS:25155-23-1 Xylenyl Phosphate View Details
3-Bromo-2-fluorophenol manufacturer Potassium Thiocyanate Cas:333-20-0 manufacturer N,N,N-Trimethyldodecan-1-aminium chloride Cas:112-00-5 manufacturer n, n-diethyl-p-phenylenediamine sulfate Cas:6065-27-6 manufacturer 1H,1H,2H,2H-Nonafluorohexyl Methacrylate Cas:1799-84-4 manufacturer